Physician profile
Satbirsingh M Risam
NPI 1639178783
$1,148.45
in general payments reported to CMS, 2019-2025
8 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.90 · 2022: $105 · 2024: $446 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $238.49 | 2025 | Ozempic |
| Astrazeneca Pharmaceuticals Lp | $229.18 | 2022-2025 | Airsupra |
| Glaxosmithkline, LLC. | $220.41 | 2024 | Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.86 | 2024-2025 | Jardiance |
| Inspire Medical Systems, INC. | $107.99 | 2025 | Inspire |
| Astellas Pharma US INC | $100.58 | 2024 | Veozah |
| Esperion Therapeutics, INC. | $92.90 | 2021 | |
| Amgen INC. | $16.04 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satbirsingh Risam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.